Houman Ashrafian

Investor type:
Locations:

Social media:

Available after registration.

Past investments

  • Enara Bio
  • Direct Flow Medical
  • Kesios Therapeutics
  • Pulmocide
  • myOrthos
  • CSA Medical
  • Avitide
  • Sutro Biopharma
  • CardioFocus
  • TopiVert
  • Aligned TeleHealth
  • LOQUS23 THERAPEUTICS
  • CytoMed Therapeutics
  • Bicycle Therapeutics
  • Jet Health
  • Centauri Health Solutions
  • PanOptica
  • Halscion, Inc.
  • Urgent Team Holdings, Inc.
  • Arsanis
  • Atopix Therapeutics
  • Bardy Diagnostics
  • EBT Medical
  • Cibiem, Inc.
  • CardioKinetix
  • Amwell
  • Avrobio
  • NKT Therapeutics
  • Pionyr Immunotherapeutics
  • Healthify
  • Zarodex Therapeutics
  • Misonix
  • Sitryx Therapeutics
  • KalVista Pharmaceuticals
  • Good Start Genetics
  • Aerocare Holdings
  • Cerevance
  • Karus Therapeutics
  • Ribometrix
  • Transposon Therapeutics
  • Spinal Kinetics
  • Catamaran Bio
  • Thesan Pharmaceuticals
  • Autifony Therapeutics
  • ReShape Lifesciences
  • Leiter's
  • Artios Pharma
  • Endotronix
  • Maestro Health
  • EBR Systems
  • ValenTx
  • AllianceCare
  • Xilio Therapeutics
  • Evidation Health
  • SUN Behavioral Health
  • Caraway Therapeutics
  • Soffio Medical
  • Zerigo Health
  • VHSquared
  • AqueSys
  • Doctors of Physical Therapy
  • AcuFocus
  • Cellinta
  • Schweiger Dermatology
  • Deciphera Pharmaceuticals
  • Delenex Therapeutics